Vasa vasorum and coronary artery disease progression: Optical coherence tomography findings

European Heart Journal Cardiovascular Imaging

Volumn 17, Issue 3, 2016, Pages 280-282

  Alfonso, Fernando ^a   De La Torre Hernández, José María ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; HEART GRAFT; HUMAN; HYPERPLASIA; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PRIORITY JOURNAL; VASA VASORUM; VASCULAR DISEASE; CORONARY BLOOD VESSEL; RADIOGRAPHY;

CORONARY ARTERY DISEASE; CORONARY VESSELS; HUMANS; TOMOGRAPHY, OPTICAL COHERENCE; VASA VASORUM;

EID: 84963961024     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev318     Document Type: Editorial

References (18)

1. Alfonso F, Macaya C, Goicolea J, Iñiguez A, Hernandez R, Zamorano J, et al. Intravascular ultrasound imaging of angiographically normal coronary segments in patients with coronary artery disease. Am Heart J 1994; 127: 536-44
2. Alfonso F, Sandoval J, Cárdenas A, Medina M, Cuevas C, Gonzalo N. Optical coherence tomography: from research to clinical application. Minerva Med 2012; 103: 441-64
3. Pollack A, Nazif T, Mancini D, Weisz G. Detection and imaging of cardiac allograft vasculopathy. JACC Cardiovasc Imaging 2013; 6: 613-23
4. Tsutsui H, Ziada KM, Schoenhagen P, Iyisoy A, Magyar WA, Crowe TD, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation 2001; 104: 653-7
5. De la Torre-Hernandez JM, de Prada JA, Burgos V, Sainz Laso F, Valls MF, Vilchez FG, et al. Virtual histology intravascular ultrasound assessment of cardiac allograft vasculopathy from 1 to 20 years after heart transplantation. J Heart Lung Transplant 2009; 28: 156-62
6. Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T, et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 2012; 33: 2513-20
7. Cassar A, Matsuo Y, Herrmann J, Li J, Lennon RJ, Gulati R, et al. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. Eur Heart J 2013; 34: 2610-7
8. Park KH, Kwon TG, Matsuzawa Y, Sun T, Liu Z, Lennon RJ, et al. Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis. Eur Heart J Cardiovasc Imaging 2016; 17: 272-9
9. Aoki T, Rodriguez-Porcel M, Matsuo Y, Cassar A, Kwon TG, Franchi F, et al. Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography-Animal and human studies. Atherosclerosis 2015; 239: 203-8
10. Campbell KA, Lipinski MJ, Doran AC, Skaflen MD, Fuster V, McNamara CA. Lynphocytes and the adventitial immune response in aterosclerosis. Circ Res 2012; 110: 889-900
11. Mulligan-Kehoe MJ, Simons M. Vasa vasorum in normal and diseased arteries. Circulation 2014; 129: 2557-66
12. Moritz R, Eaker DR, Anderson JL, Kline TL, Jorgensen SM, Lerman A, et al. IVUS detection of vasa vasorum blood flow distribution in coronary artery vessel wall. JACC Cardiovasc Imaging 2012; 5: 935-40
13. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996; 94: 1655-64
14. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes DR Jr, Richardson DM, Ritman EL, et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 2001; 51: 762-6
15. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR Jr, Schwartz RS, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998; 101: 1551-6
16. Gössl M, Herrmann J, Tang H, Versari D, Galili O, Mannheim D, et al. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol 2009; 104: 695-706
17. Herrmann J, Best PJ, Ritman EL, Holmes DR Jr, Lerman LO, Lerman A. Chronic endothelin receptor antagonism prevents. Coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Am Coll Cardiol 2002; 39: 1555-61
18. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349: 2316-25